Summary.
There is increasing interest in the identification of biological markers for the early diagnosis of Parkinson's disease (PD). Previous studies indicate changes of dopamine content, tyrosine hydroxylase immunoreactivity and dopamine receptors in peripheral blood lymphocytes (PBL) in PD. Here we demonstrate a reduction of dopamine transporter immunoreactivity in PBL in the early clinical stages of the disease. These findings contribute to our understanding of the peripheral dopamine system in PD.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received November 16, 2000; accepted March 19, 2001
Rights and permissions
About this article
Cite this article
Caronti, B., Antonini, G., Calderaro, C. et al. Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease. J Neural Transm 108, 803–807 (2001). https://doi.org/10.1007/s007020170030
Issue Date:
DOI: https://doi.org/10.1007/s007020170030